Sera Prognostics: Few Takers For A Great Product Spells Angst (NASDAQ:SERA)

Core Insights - Sera Prognostics has experienced a noticeable cooling in its performance after a previous hot streak, leading to a reevaluation of its investment status from "Hold" [1] Company Overview - The article reflects on the author's investment journey, emphasizing the learning process involved in investing, particularly in healthcare stocks [1] Investment Perspective - The author shares insights from decades of investing experience and focused research on various stocks, with a recent emphasis on healthcare [1]